Skip to content

Wii STAR - Wii Stroke Therapy for Arm Rehabilitation

A low cost virtual reality system for home based rehabilitation of the upper limb following stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN42229581
Enrollment
60
Registered
2011-04-18
Start date
2009-09-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke Rehabilitation Circulatory System Stroke

Interventions

Control Group: Patients in the control group are to receive normal care but will receive no direct intervention from the research team Intervention Group: 1. Patients will be invited to start the t

Sponsors

The University of Nottingham (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 or over 2. Have a confirmed diagnosis of their first stroke 3. Are no longer receiving any other rehabilitation therapy (community stroke team, intermediate care, early supported discharge) 4. Have residual upper limb dysfunction

Exclusion criteria

Exclusion criteria: 1. Patients with no detectable movement in the upper limb as research has shown (Parry et al, 1999) that these patients cannot benefit from rehabilitation 2. Patients with pre-morbid disability in upper limb function 3. Patients unable to follow a two stage command 4. Patients living in a care home as their compliance is likely to be compromised by additional factors that would make results difficult to interpret 5. Patients with any of the following: 5.1. Severe symptomatic arm/shoulder pain 5.2. Severe visual impairments 5.3. Other neurological illnesses such as head injury or multiple sclerosis 5.4. Unstable medical condition 5.5. Psychiatric illness 5.6. Epilepsy triggered by screen images 5.7. Cardiac pacemaker 6. Patients unable to tolerate sitting in a chair for 30 minutes 7. Patients unable to complete a baseline test on the VR system (intervention group only)

Design outcomes

Primary

MeasureTime frame
1. Wolf Motor Functions Test (WMFT) (Wolf et al, 1989) this is a measure of upper limb functioning that gives both joint specific and total limb information 2. Patients complete 17 timed tasks ordered in terms of complexity involving simple limb movement (such as flipping over cards). It is an outcome measure used in most comparable studies 3. This will be taken at baseline, 5 weeks and 10 weeks (end of intervention period) for both the intervention and control group

Secondary

MeasureTime frame
1. Nine-Hole Peg Test (Kellor et al, 1971) - a timed test of fine motor co-ordination. Patients place 9 pegs from a container into a wooden block with 9 empty holes one at a time, once completed the patients then have to remove the pegs and place them back in the container as quickly as possible 2. Nottingham Extended Activities of Daily Living (NEADL) (Nouri & Lincoln, 1987) this is a measure of functional ability that is commonly used in studies of stroke rehabilitation 3. It has four subscales: 3.1. Mobility 3.2. Kitchen tasks 3.3. Domestic tasks 3.4. Leisure activities measured on a Likert scale (0 = not at all, to 3 = on your own easily). 4. Motor Activity Log (MAL) (Taub et al, 1993, 1996) - a structured interview in which participants are asked a set of standardised questions aiming to examine the extent of (amount of use), and quality of use of their affected upper limb during 30 common ADLs outside of a laboratory or clinical setting. Participants indicate their responses on two set rating scales. 5. These will be taken at baseline, 5 weeks and 10 weeks (end of intervention period) for both the intervention and control group 6. For the intervention group the frequency of use of the equipment will be collected by the software and the frequency of requests for help and type of queries when using the equipment will be logged by the research team to provide information on feasibility of using the equipment and aspects of the intervention that may influence its adoption

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026